Citation Impact
Citing Papers
Beta Blockers and Breast Cancer Mortality: A Population- Based Study
2011
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
2018 Standout
Autonomic Nerve Development Contributes to Prostate Cancer Progression
2013 StandoutScience
A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT Atherosclerosis Study
2002
Pulmonary Embolism
1998
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
2020 Standout
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
1998 Standout
The renin–angiotensin system and cancer: old dog, new tricks
2010
Psoriasis
2009 Standout
Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>
1999 Standout
Statins and the risk of dementia
2000
Prophylaxis of Pneumocystis Pneumonia in Immunocompromised Non-HIV-Infected Patients: Systematic Review and Meta-analysis of Randomized Controlled Trials
2007
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
2002 Standout
Early Identification of Refractory Epilepsy
2000 Standout
Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up
2001
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Role of acute infection in triggering acute coronary syndromes
2010
Kinetic study of paracetamol on prolidase activity in erythrocytes by capillary electrophoresis with Ru(bpy)32+ electrochemiluminescence detection
2006
Time to Treatment and Mortality during Mandated Emergency Care for Sepsis
2017 Standout
Influenza Infection and Risk of Acute Myocardial Infarction in England and Wales: A CALIBER Self-Controlled Case Series Study
2012
Estrogens, Episodic Memory, and Alzheimer's Disease: A Critical Update
2009
Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy
2002 Standout
Challenges associated with identifying the environmental determinants of the inflammatory bowel diseases
2010
Estrogen receptor α is a major mediator of 17β-estradiol’s atheroprotective effects on lesion size in Apoe–/– mice
2001 StandoutNobel
Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
2005 Standout
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
Influenza and the Winter Increase in Mortality in the United States, 1959-1999
2004
Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
2014 Standout
Plasma Ghrelin Levels after Diet-Induced Weight Loss or Gastric Bypass Surgery
2002 Standout
Reduced Risk of Breast Cancer Recurrence in Patients Using ACE Inhibitors, ARBs, and/or Statins
2011
Echocardiographic Improvement Over Time After Cessation of Use of Fenfluramine and Phentermine
1999
Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs
1994 Standout
Inflammatory Bowel Disease
2009 Standout
Effects of Hormone-Replacement Therapy on Fibrinolysis in Postmenopausal Women
1997
A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1
2011 StandoutNatureNobel
Long-Term Prognosis of Seizures with Onset in Childhood
1998
Inflammatory bowel disease is not associated with an increased risk of lymphoma
2001
Absence of Cardiac Valve Dysfunction in Obese Patients Treated with Sibutramine
1999
Incidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism
2004 Standout
Risk of Myocardial Infarction in Patients With Psoriasis
2006
Mechanisms involved in the side effects of glucocorticoids
2002 Standout
Echocardiographic Examination of Women Previously Treated With Fenfluramine
2001
Risk of venous thromboembolism in users of hormone replacement therapy
1996
Lower Risk of Thromboembolic Cardiovascular Events With Naproxen Among Patients With Rheumatoid Arthritis
2002
Current status of medical and surgical therapy for obesity
2001
Cardiovascular Risk Factors and Venous Thromboembolism Incidence
2002
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
2001 Standout
Appetite suppressants and valvular heart disease in a population-based sample: the HyperGEN study
2002
Inflammatory Bowel Disease
2002 Standout
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
2008 Standout
Reversal of Phen-Fen associated valvular regurgitation documented by serial echocardiography
2002
Malignant Gliomas in Adults
2008 Standout
Recent trends in physician diagnosed COPD in women and men in the UK
2000
The influence of bio-behavioural factors on tumour biology: pathways and mechanisms
2006
A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial Fibrillation
2002 Standout
Valvular Abnormalities and Cardiovascular Status Following Exposure to Dexfenfluramine or Phentermine/Fenfluramine
2000
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
1999 Standout
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
2013 StandoutNobel
Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer
2003 Standout
Estrogen plus Progestin and the Risk of Coronary Heart Disease
2003 Standout
Alzheimer's Disease
2010 Standout
Effect of fenfluramine-derivative diet pills on cardiac valves: A meta-analysis of observational studies
2002
Long-term Pharmacotherapy of Obesity 2000
2001
Assessment and Control for Confounding by Indication in Observational Studies
1999
Immunosuppressant Medications and Mortality in Inflammatory Bowel Disease
2008
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
2017 Standout
Production and Actions of Estrogens
2002 Standout
Appendectomy and Protection against Ulcerative Colitis
2001
Epidemiology and prevention of bladder cancer
2001
Evaluating Medication Effects Outside of Clinical Trials: New-User Designs
2003 Standout
Risk of Myocardial Infarction and Stroke after Acute Infection or Vaccination
2004
Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness
2003 Standout
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
A Critical Review of Epidemiological Studies in Inflammatory Bowel Disease
2001
Helminths and Mucosal Immune Modulation
2006
Postmenopausal Hormone Therapy Increases Risk for Venous Thromboembolic Disease: The Heart and Estrogen/progestin Replacement Study
2000
Extended Work Shifts and the Risk of Motor Vehicle Crashes among Interns
2005 Standout
Molecular Mechanisms of Amyloidosis
2003 Standout
Availability of large-scale evidence on specific harms from systematic reviews of randomized trials
2004
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Diabetes in urban african americans. III. Management of type II diabetes in a municipal hospital setting
1996
Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34 892 subjects
2007
Hormone replacement therapy and risk of venous thromboembolism: population based case-control study
1997
Dose and duration of fenfluramine-phentermine therapy impacts the risk of significant valvular heart disease
2000
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Influenza-like illness in acute myocardial infarction patients during the winter wave of the influenza A H1N1 pandemic in London: a case–control study
2013
The Progression of Fenfluramine-Associated Valvular Heart Disease Assessed by Echocardiography
2001
Coping Strategies in People with Insulin-Dependent Diabetes Mellitus
1993
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Fenfluramine and Phentermine and Cardiovascular Findings
2000
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Evidence for Possible Involvement of 5-HT2BReceptors in the Cardiac Valvulopathy Associated With Fenfluramine and Other Serotonergic Medications
2000
The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics
2002 StandoutScience
A Prospective, Observational Study of Postmenopausal Hormone Therapy and Primary Prevention of Cardiovascular Disease
2000
Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease
2006 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Should We Use a Case-Crossover Design?
2000
Noncardiovascular disease outcomes during 6.8 years of hormone therapy. heart and estrogen/progestin replacement study follow-up (HERS II)
2002
Factors Associated With Ischemic Stroke During Aspirin Therapy in Atrial Fibrillation
1999
HORMONE REPLACEMENT THERAPY, HEART DISEASE, AND OTHER CONSIDERATIONS
1998
Acute Systemic Inflammation Impairs Endothelium-Dependent Dilatation in Humans
2000
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Electrogenerated Chemiluminescence and Its Biorelated Applications
2008 Standout
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
2002 Standout
Natural History of Valvular Regurgitation 1 Year after Discontinuation of Dexfenfluramine Therapy
2001
Ischaemic heart disease, influenza and influenza vaccination: a prospective case control study
2013
A Critical Review of Epidemiological Studies in Inflammatory Bowel Disease
2001
Antiestrogens and Selective Estrogen Receptor Modulators as Multifunctional Medicines. 2. Clinical Considerations and New Agents
2003
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Recent Epidemiological Studies of the Association Between Hormone Replacement Therapy and Venous Thromboembolism
1998
Treatment of Periodontitis and Endothelial Function
2007 Standout
Works of Laura E. Derby being referenced
A Large Population‐Based Follow‐Up Study of Trimethoprim‐Sulfamethoxazole, Trimethoprim, and Cephalexin for Uncommon Serious Drug Toxicity
1995
Acute respiratory-tract infections and risk of first-time acute myocardial infarction
1998
Sudden Unexplained Death Among Subjects with Refractory Epilepsy
1996
Angiotensin-Converting Enzyme Inhibitors, Calcium Channel Blockers, and Breast Cancer
2000
Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens
1996
A Population-Based Study of Appetite-Suppressant Drugs and the Risk of Cardiac-Valve Regurgitation
1998
Antihypertensive Drugs and Fatal Myocardial Infarction in Persons with Uncomplicated Hypertension
1997
Postmenopausal Estrogen Replacement Therapy and the Risk of Alzheimer Disease
2001
Risk of cataract among users of intranasal corticosteroids
2000
Acetaminophen and Renal and Bladder Cancer
1996
Psychological Characteristics of Adults With IDDM: Comparison of Patients in Poor and Good Glycemic Control
1990
Further validation of information recorded on a general practitioner based computerized data resource in the united kingdom
1992
Clinic Attendance and Glycemic Control: Study of Contrasting Groups of Patients With IDDM
1991
Risk of Hospital Admission for Idiopathic Venous Thromboembolism Among Users of Postmenopausal Oestrogens
1997
Appendectomy Protects against Ulcerative Colitis
1998
The Risk of Myocardial Infarction Associated with Antihypertensive Drug Treatment in Persons with Uncomplicated Essential Hypertension
1996